2026 Q1 -tulosraportti
Vain PDF
52 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·20 t sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
·3 päivää sittenSo patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out- ·3 päivää sittenI have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/
I am a relatively new shareholder in STENOCARE and would therefore like to hear if you would share your thoughts behind the decision to sell all your shares. Is there anything I should be aware of or have missed, and that I should be concerned about. - ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
·23.6. · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
52 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·20 t sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·3 päivää sittenSo patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out
- ·3 päivää sittenI have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/I am a relatively new shareholder in STENOCARE and would therefore like to hear if you would share your thoughts behind the decision to sell all your shares. Is there anything I should be aware of or have missed, and that I should be concerned about.
- ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
- ·23.6. · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
52 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·20 t sittenI just stumbled upon this documentary film about how easy it is to get flower cannabis medicine on prescription, in Germany. This is right up Minister of Health Nina Warkens' alley, because she has been a fierce opponent of flowers and vaporizers receiving subsidies when the bill was to be approved. Subsequently, she became Minister of Health, and now that she is minister, her views have only been strengthened by the fact that the expenses for flowers and vaporizers have increased by 400% in 2 years. (see previous link) Even though the proposal has only gone through its 1st reading, there is probably no doubt that it will also pass the 2nd and 3rd readings. One's death is another's bread. I wonder if some of these users will get prescriptions for Weeco astrum10-10 instead. https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·3 päivää sittenSo patience ran out sold and Circio Holding bought.... have a nice day and good luck to those of you who are still holding out
- ·3 päivää sittenI have written several times that the subsidy for flowers and vapor will end as of January 1, 2027. Since I could not see any signs that the industry itself, which deals with flowers and vapor, did not seem to react and start getting oils and extracts into their assortment, I began to wonder if I am the only one who has seen it and understood that the subsidy is stopping? No, fortunately, that's not the case, Weeco pharma has also understood it. This summer they are running an aggressive campaign, simultaneously with a campaign for Weeco astrum, so that new customers (B2B) can buy 1 kg. flower medicine cheaply while supplies last. This campaign is to snatch as many new customers as possible from businesses that only deal with flowers and vapor, so that before the subsidy is removed, they get Weeco astrum into their assortment. Unfortunately, it's not only Weeco Pharma that is being aggressive, the other wholesalers are too. https://weeco.com/https://weeco.com/astrum/I am a relatively new shareholder in STENOCARE and would therefore like to hear if you would share your thoughts behind the decision to sell all your shares. Is there anything I should be aware of or have missed, and that I should be concerned about.
- ·23.6. · MuokattuBonus info, while we wait for Q2 to end. In my search for this and that, I have also come across other information about the German health insurance fund. (Krankenkasse) as a side benefit, to understand why Weeco Astrum 10-10, in Germany, will become valuable for Stenocare, and the reason why Weeco Astrum 10-10 will not be affected by the major savings proposal for 2027, which has just passed its 1st reading. If you are curious, please read on. I will also take the opportunity to correct misunderstandings about the German health insurance system. It is incredibly complicated, not even German citizens understand it, but I will simplify it. The German health insurance fund is the overarching body, and they determine the maximum price for how much common medicine, e.g., painkillers, and cannabis medicine, may cost. Under this body, we have the German health insurance companies. Although they are called health insurance companies, they are all public. In Germany, there are 95 insurance companies of various sizes; these cover all German citizens in Germany. It is mandatory for all citizens to be members of an insurance company. (there are also private ones, but I will exclude them from this) These insurance companies do not cover the same things, and you might think it's a lie, but these 95 companies compete among themselves for customers. That is also why not all German citizens can get subsidies for Weeco Astrum 10-10 if they are members of a company that has not approved the oil for reimbursement. Only those who are members of TK and AOK receive reimbursement. When a citizen redeems a prescription, at the pharmacy or online, for Weeco Astrum 10-10, we have seen that there are slightly different prices for the oil, but that is because not everyone has their insurance with Techniker Krankenkasse (TK) and AOK. Those persons who are not insured with the above pay themselves, and it becomes the expensive price. The citizens who receive reimbursement pay 0 kr. for the oil, and the pharmacy sends the bill directly to the above companies. But there is a co-payment for getting a prescription issued, which varies slightly in price depending on who issues the prescription. I have seen different prices for online e-prescriptions. The insurance companies Techniker Krankenkasse (TK) and AOK have approved the oil for reimbursement, fast track, and for sale in Germany. TK has 12.5 mill. members AOK is 11 smaller insurance companies, gathered in an association called AOK. (but it is still 11 companies out of the 95) Together they have 27 mill. members Then we must also add the feared clawback, Regress, for doctors. It is quite simple: doctors must repay out of their own pocket to the health insurance fund if they exceed the budget they receive every 3 months. This means that if the doctor prescribes medicine that is not approved by one or more health insurances, the bill goes to the overarching health insurance fund, and if the doctors exceed the budget they are sent every 3 months, then those doctors who have exceeded this budget must pay the difference themselves. Which doctors both hate and fear, so they are very careful to adhere to these budgets. But when a medicine is approved for 100 % reimbursement, like Weeco Astrum 10-10, it will not come out of the doctors' own pockets, because it is the insurance companies that have approved it for reimbursement that pay for the medicine, and not the health insurance fund. I know, it's the same fund, but that's how the health insurance law is. The reason why Grunhorn (which is one of the large platforms) does not have Weeco Astrum in stock is possibly because they themselves mix Cannabis flowers for vaporizers and oil, based on what the doctor writes on the prescription. When Astrum is not affected by the major savings plans in 2027, it is because it is pre-mixed in a factory, and not a pharmacy, and because it is not flower medicine and vaporizers. see link. Pharmacies, flower, and vaporizer businesses will be affected when the bill comes into force in 2027 They will be, because German citizens will have to pay for vaporizers and flower medicine themselves, which most cannot afford, and because doctors will not want to risk clawback, they will start prescribing Cannabis oils and extracts. In addition to pharmacies and Grunhorn selling flowers and vaporizers, they also mix cannabis oils themselves, and this has been a lucrative business, but new laws, fixed prices, and high prices for this and that mean that the profit becomes so small that it is not worth mixing themselves. This market will gradually be taken over by pre-mixed products, such as Astrum, other oils, and extracts. Due to lack of space, see links in the next post.Link to the fact that it does not pay to mix yourself. https://www.apotheke-adhoc.de/branchennews/alle-branchennews/branchennews-detail/preisberechnung-von-medizinalcannabisblueten/# Ordinary medicine is not expected to be affected by savings, as well as pre-mixed oils and extracts. https://www.bundesgesundheitsministerium.de/service/gesetze-und-verordnungen/guv-21-lp/gkv-beitragssatzstabilisierungsgesetz-faq
- ·23.6. · MuokattuTA 23/7/26 https://www.tradingview.com/x/kyRYP5Mz/ Volume is clearly one of the best tools when looking for support/resistance. We have a High Volume Note (HVN) at approx. 1.445 DKK., which time and again has sent the price down again when it has been hit. https://www.tradingview.com/x/QagFNwtG/ On top of that, as confluence, lies AWAP, which I have drawn from the top. In short, it means that the biggest resistance is at 1,445. https://www.tradingview.com/x/HvgyqMiM/ Here a range is seen more locally. I have explained with text on the image what has happened. https://www.tradingview.com/x/YSyrYwsU/ The theory behind this with a range or VAL, POC and VAH is that the price always starts by being rejected or accepted. POC is the price level where most trading has occurred with the largest volume. That is, where buyers and sellers have agreed on a fair price. It always acts as a strong magnet for the price, as well as strong resistance or support. The price can run in a range for a few minutes or many years.. It depends on how much data one looks back at. But always think that the price must either be rejected or accepted into VAL, POC and VAH. In the end, either buyers win, so we move up above the range, or down below, if sellers continue. Until then, we are in a consolidation phase, where we try to agree on the correct price. https://www.tradingview.com/x/BqKalHgd/ If we go by the book, the price is in the process of being accepted into VAL. If we do that, we should look for the price to rise towards POC (1,145-1,47). https://www.tradingview.com/x/f1bFvWkz/ If the price, however, is rejected at VAL, I see the next support at 0,75. Personally, I still hold a good portion from 0,52 DKK, so I'm still sitting pretty. I still believe in the project and am still holding on :) My whole write-up went a bit fast, so there might be typos or perhaps something you don't understand. You are welcome to ask questions about it all Also, I would be grateful if ALL comments that have nothing to do with my TA could be posted elsewhere... :) Have a good day!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt